A006

· Amphastar Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for A006, covering 2017-04-19 to 2017-07-02. Get the full timeline:

Most recent: Clinical Trial Update: Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006 [Phase 2]